Targeting myofilament proteins in heart failure and cardiomyopathies
Chair: S. T. Sossalla (Regensburg), H. Bugger (Graz, AT)
| 13:30 | (V46) | Introduction |
| S. T. Sossalla (Regensburg) | ||
| 13:35 | (V47) | Myofilament contraction and relaxation in health and disease |
| T. Kraft (Hannover) | ||
| 13:50 | Discussion | |
| 13:55 | (V48) | Myofilaments and energy deficiency in hypertrophic cardiomyopathy |
| J. van der Velden (Amsterdam, NL) | ||
| 14:10 | Discussion | |
| 14:15 | (V49) | Titin-based stiffness in diabetic cardiomyopathy and modulators for potential treatment |
| M. Krüger (Düsseldorf) | ||
| 14:30 | Discussion | |
| 14:35 | (V50) | Cardiac α‐actin (ACTC1) gene mutation cause atrial‐septal defects associated with dilated cardiomyopathy |
| D. Frank (Kiel) | ||
| 14:50 | Discussion | |
| 14:55 | (V51) | Closing remarks |
| H. Bugger (Graz, AT) | ||
| Mitgliederversammlung und Wahlen der AG13 am Mittwoch, 24. April 2019 15:00 - 15:30 Uhr in Saal 11 |
| 15:00 - 15:30 | Break |